Though the endocannabinoid process is challenging rather than nevertheless properly comprehended; not one person has yet administered endocannabinoids to individuals, leaving what Mechoulam sees as being a gaping gap of data, and a huge opportunity. “I think that we are missing quite a bit,” he suggests.It is often described as currently being